Document
Academic Article
RDF description of Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment - http://irises.unisr.it/resource/item/225818
Generically Dependent Continuant
Article
Information Content Entity
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment